Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER®)
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER®)
This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.
Study Type: Interventional (Clinical Trial)
Actual Enrollment: 9340 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Actual Study Start Date: August 31, 2010
Actual Primary Completion Date: December 17, 2015
Actual Study Completion Date: December 17, 2015
Arms:
- Experimental: Liraglutide
- Placebo Comparator: Placebo
| Category | Value |
|---|---|
| Date last updated at source | 2019-01-01 |
| Study type(s) | Interventional |
| Expected enrolment | 9340 |
| Study start date | 2010-08-31 |
| Estimated primary completion date | 2015-12-17 |